Smoking Linked to Substantial Brain Volume Loss as Experts Warn of Global Cognitive Health Burden

A meta-analysis finds tobacco use causes significant loss in brain gray matter and amygdala volume, while cannabis shows weaker but notable structural effects.

By: AXL Media

Published: Apr 7, 2026, 5:57 AM EDT

Source: Information for this report was sourced from Dr. Liji Thomas, MD

The Neurobiological Toll of Tobacco Combustion

Tobacco use, which currently affects approximately 1.18 billion people globally, has been definitively linked to structural changes in the human brain. According to a new study led by Dr. Liji Thomas, nicotine acts on acetylcholine receptors distributed throughout the brain, triggering a cascade of neurobiological shifts. Cross-sectional and Mendelian randomization (MR) studies consistently showed smaller volumes in the amygdala, insula, and pallidum among smokers compared to non-smokers. Most notably, longitudinal data revealed a significant reduction in total gray matter volume over time, suggesting that the habit may accelerate neuronal death through persistent oxidative stress and systemic inflammation.

Cannabis and the Complexity of THC Exposure

While cannabis use is rising globally—reaching an estimated 228 million people in 2022—the evidence regarding its impact on brain structure remains less consistent than that of tobacco. The study found that cannabis users often exhibit smaller amygdala volumes, a region critical for emotional processing. However, unlike tobacco, longitudinal studies on cannabis yielded mixed results, with significant volume reductions primarily observed in individuals already at risk for schizophrenia. Researchers noted that while tetrahydrocannabinol (THC) affects the brain's abundant CB1 receptors, the presence of cannabidiol (CBD) in some products might partially counteract the inflammatory toxins produced during combustion.

The Rise of High-Potency Products

A significant concern highlighted by the research team is the evolving nature of cannabis consumption. Increasingly potent products are becoming more common in the global market, and these higher-strength variants are linked to a greater risk of addiction and mental health disorders. The study suggests that as potency increases, the potential for structural brain changes may also rise, though current research has yet to fully account for drug strength or the severity of use. Experts warn that the global trend toward legalization and increased accessibility necessitates a more disciplined approach to studying the long-term cognitive effects of high-THC exposure.